Cargando…
Safety and efficacy of pharmacologic weight loss in patients with cirrhosis
BACKGROUND: Obesity poses unique risks in patients with advanced liver fibrosis; however, given surgical risks of bariatric surgery in cirrhosis treatment recommendations are currently limited to lifestyle interventions. This study seeks to inform a potential treatment gap by describing the safety a...
Autores principales: | Fakhreddine, Ali Y., Bagsic, Samantha, Fujioka, Ken, Frenette, Catherine T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019275/ https://www.ncbi.nlm.nih.gov/pubmed/33841885 http://dx.doi.org/10.1002/osp4.469 |
Ejemplares similares
-
A Practical Review of Cytomegalovirus in Gastroenterology and Hepatology
por: Fakhreddine, Ali Y., et al.
Publicado: (2019) -
Efficacy and safety of COVID-19 vaccination in patients with cirrhosis
por: Ivashkin, Vladimir, et al.
Publicado: (2022) -
Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door
por: Frenette, Catherine T., et al.
Publicado: (2021) -
Efficacy and safety of an oral device to reduce food intake and promote weight loss
por: Ryan, D. H., et al.
Publicado: (2017) -
Efficacy and safety of laparoscopic hepatectomy for hepatocellular carcinoma comorbid with cirrhosis
por: Inoue, Yoshihiro, et al.
Publicado: (2020)